TrialCancer2014

Risk factors for clinician-reported symptom clusters in patients with advanced head and neck cancer in a phase 3 randomized clinical trial: RTOG 0129.

Canhua Xiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.